• Ju Fu Tang Biotech will hold its annual general meeting in Central, Hong Kong on Sept. 10, 2026.
• Shareholders will vote to adopt the audited consolidated financial statements for the year ended March 31, 2026.
• Resolutions include re-electing Yu Xiao as executive director, Lao In Iam as independent non-executive director, reappointing Infinity CPA as auditor.
• Mandates up for approval include issuing up to 20% of existing shares, repurchasing up to 10%, extending the issue mandate by shares repurchased.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ju Fu Tang Biotech Holdings Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260731-12263719), on July 31, 2026, and is solely responsible for the information contained therein.